521 related articles for article (PubMed ID: 19033823)
1. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
2. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
3. Coronary vasomotor response to the selective B1-kinin-receptor agonist Des-Arg9-bradykinin in humans.
Aptecar E; Lecorvoisier P; Teiger E; Garot P; Dupouy P; Sediame S; Vermes E; Loisance D; Hittinger L; Dubois-Rande JL; Montagne O
J Heart Lung Transplant; 2006 Feb; 25(2):187-94. PubMed ID: 16446219
[TBL] [Abstract][Full Text] [Related]
4. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb.
Cruden NL; Lang NN; MacGillivray TJ; Uren NG; Fox KA; Newby DE
Heart Vessels; 2012 Mar; 27(2):179-85. PubMed ID: 21394642
[TBL] [Abstract][Full Text] [Related]
5. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
[TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
8. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
9. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
10. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.
Wille PR; Vitor R; Gabilan NH; Nicolau M
Mediators Inflamm; 2001 Jun; 10(3):163-7. PubMed ID: 11545253
[TBL] [Abstract][Full Text] [Related]
11. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
Tiritilli A; El Habach T; Haury L; Duret JF
Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
[TBL] [Abstract][Full Text] [Related]
12. Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileum.
Chan SK; Rudd JA
Eur J Pharmacol; 2006 Jun; 539(1-2):108-15. PubMed ID: 16650846
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.
Cunha TM; Verri WA; Fukada SY; Guerrero AT; Santodomingo-Garzón T; Poole S; Parada CA; Ferreira SH; Cunha FQ
Eur J Pharmacol; 2007 Nov; 573(1-3):221-9. PubMed ID: 17669394
[TBL] [Abstract][Full Text] [Related]
14. Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species.
Wohlfart P; Dedio J; Wirth K; Schölkens BA; Wiemer G
J Pharmacol Exp Ther; 1997 Feb; 280(2):1109-16. PubMed ID: 9023330
[TBL] [Abstract][Full Text] [Related]
15. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
16. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin.
Eisenbarth H; Rukwied R; Petersen M; Schmelz M
Pain; 2004 Jul; 110(1-2):197-204. PubMed ID: 15275768
[TBL] [Abstract][Full Text] [Related]
18. des-Arg9-bradykinin produces tone-dependent kinin B1 receptor-mediated responses in the pulmonary vascular bed.
DeWitt BJ; Cheng DY; Kadowitz PJ
Circ Res; 1994 Dec; 75(6):1064-72. PubMed ID: 7955144
[TBL] [Abstract][Full Text] [Related]
19. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]